Ticker Symbol: FOLD
Amicus Therapeutics Inc
$12.00 - 17-09-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001178879
Company Profile
Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 1 Cedarbrook Dr
Website: www.amicusrx.com
CEO: John Crowley
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $11.03
Change:
-
(
0.00%)
Days Range: $10.94 - $11.33
Beta: 0.77
52wk. High: $14.10
52wk. Low: $9.10
Ytd. Change -9.66%
50 Day Moving Average: $11.80
200 Day Moving Average: $12.23
Shares Outstanding: 287120937
Valuation
Market Cap: 316.7B
PE Ratio: -17.26
EPS (TTM): -0.6391
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A